S100A8 and T-cell acute lymphoblastic leukemia: In a recent study on relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoma patients undergoing anti-CD7 CAR-T therapy, scRNA-seq demonstrated high expression of S100A8 in various T cell subpopulations in the relapsed patients (35).